Eupalinolide K is primarily studied for its anti-inflammatory and anti-cancer properties. It has shown potential in inhibiting the growth of certain tumor cells by inducing apoptosis and suppressing cell proliferation. Research indicates it may modulate key signaling pathways involved in inflammation and cancer progression, such as NF-κB and MAPK pathways. Due to these biological activities, Eupalinolide K is considered a candidate for development in oncology and inflammatory disease therapeutics. It is also used in pharmacological studies to explore natural product-derived compounds with cytotoxic effects on cancer cells.